Compare SENEA & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SENEA | GERN |
|---|---|---|
| Founded | 1949 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.0B |
| IPO Year | 1998 | 1996 |
| Metric | SENEA | GERN |
|---|---|---|
| Price | $208.77 | $1.59 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.17 |
| AVG Volume (30 Days) | 72.7K | ★ 10.5M |
| Earning Date | 06-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 51.85 |
| EPS | ★ 2.85 | N/A |
| Revenue | ★ $1,314,765,000.00 | $1,065,000.00 |
| Revenue This Year | N/A | $26.91 |
| Revenue Next Year | N/A | $43.75 |
| P/E Ratio | $72.74 | ★ N/A |
| Revenue Growth | ★ 4.16 | N/A |
| 52 Week Low | $99.58 | $1.04 |
| 52 Week High | $209.06 | $2.01 |
| Indicator | SENEA | GERN |
|---|---|---|
| Relative Strength Index (RSI) | 75.25 | 57.53 |
| Support Level | $134.17 | $1.46 |
| Resistance Level | N/A | $1.64 |
| Average True Range (ATR) | 6.01 | 0.07 |
| MACD | 1.15 | -0.00 |
| Stochastic Oscillator | 94.92 | 80.56 |
Seneca Foods Corp is a provider of packaged fruits and vegetables. The facilities are comprised of plants for packaging, can manufacturing, seed production, a farming operation and a logistical support network. It manages its business almost entirely on the basis of two reportable food packaging segments: Vegetable and Fruit/Snack. Majority of revenue comes from Vegetable segment. The Other category comprises non-food operations including revenue derived from the sale of cans, ends, seed, and outside revenue from the company's aircraft operations, and certain corporate items. Its principal product offerings include canned, frozen and jarred fruits and vegetables, as well as packaged snack chips. Its brands are Aunt Nellie's, Cherry man, GREEN VALLEY, Libby's, READ, and SENECA APPLE CHIPS.
Geron Corp is a biopharmaceutical company focused on blood cancers. Its telomerase inhibitor, RYTELO (imetelstat), is approved in the United States and European Union for certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion-dependent anemia. RYTELO inhibits telomerase activity in malignant stem and progenitor cells, which may reduce abnormal cell proliferation while supporting the production of healthy cells. It is also conducting a Phase 3 trial of imetelstat in patients with JAK-inhibitor-refractory or relapsed myelofibrosis (R/R MF) and studies in other hematologic malignancies. The company operates as a single segment, being the development of therapeutic products for oncology.